Literature DB >> 1082700

A two compartment open model for digoxin pharmacokinetics in patients receiving a wide range of digoxin doses.

S W Rabkin, G Grupp.   

Abstract

The pharmacokinetic parameters for a two compartment open model were defined for six patients receiving a wide range of Digoxin doses. It was demonstrated that the two compartment model is a valid one to use for Digoxin pharmacokinetics. This model is an useful concept because it can explain the necessity to vary Digoxin dosage in patients with different body weights, the time course of the effect of Digoxin and certain causes of increased tolerance to Digoxin. There were no alterations in the parameters of this model or of the percent of an injected Digoxin dose excreted in the urine and stool in our patients in atrial fibrillation who appeared to require larger doses to control their ventricular rates. This also suggests that the kinetics of excretion of Digoxin are not influenced by altering the Digoxin dose.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1082700

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  9 in total

Review 1.  Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

2.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

3.  Skeletal muscle digoxin concentration during digitalization and during withdrawal of digoxin treatment.

Authors:  T Jogestrand; F Ericsson; K Sundqvist
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

4.  Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.

Authors:  E Yukawa; F Suematu; M Yukawa; M Minemoto; S Ohdo; S Higuchi; Y Goto; T Aoyama
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

6.  Absorption of digoxin in severe right heart failure.

Authors:  E E Ohnhaus; S Vozeh; E Nuesch
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

7.  Transient changes in plasma digoxin concentration and the development of cardiotoxicity.

Authors:  D J Chapple; R Hughes; B F Johnson
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

8.  Comparison of two different loading doses of digoxin in severe renal impairment.

Authors:  E E Ohnhaus; H R Lenzinger; R L Galeazzi
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

9.  Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment.

Authors:  K O Haustein
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.